A 2024 study comparing tirzepatide to semaglutide found that people taking tirzepatide lost significantly more weight than those taking semaglutide
However, subtle changes may begin to emerge: Slight reduction in appetite: Even though the weight loss itself may not be obvious, a decrease in appetite and cravings may begin to surface, setting the stage for better eating habits in the weeks ahead
Delayed gastric emptying The medication delays gastric emptying, which is the most common reason for nausea
In todays era, mobile phones have become indispensable tools in our daily lives, serving critical roles in business, commerce, education, and emergency communication
NovoCare Wegovy pill self-pay (1.5 mg) : $1,788/year ($149/mo)